← All candidates
70 insider filings on record.
70 filings on record.
ORGOOrganogenesis Holdings Inc.
—
$2.36
-3.28% · Jul 2
70 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 4 sells◆ 3 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Nussdorf Glenn H
Bought $775.0K on May 14 — 251,001 sh @ $3.09, held indirect, 100% of their stake.
1 of 1 position beat the S&P
Chief Admin. and Legal Officer
Freedman Lori
Bought $413.6K on Jun 5 — 142,379 sh @ $2.91, held direct, 17% of their stake.
1 of 1 position beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
65 more transactions on Pro →Context
Wall St
$2.00 avg target
-15.3% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q2 '26−$0.69 act−$0.34
Q1 '26−$0.34 act−$0.05
Q4 '25$0.40 act+$0.19
Q3 '25$0.18 act+$0.11
Coverage
Organogenesis (ORGO) Q2 2026 Earnings Call TranscriptMotley Fool · 08-13Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst CautionSimply Wall St. · 08-10Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed?Simply Wall St. · 08-08Organogenesis Holdings Inc. Q2 2026 Earnings Call SummaryMoby · 08-07
The file stays open
70 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice